Key Pharma News published by Espicom Business Intelligence. This newsletter price starts from US $ 1025.
A new business publication which keeps busy executives easily in touch with the rapidly changing developments in pharmaceutical companies. PCI focuses on the activities of companies and provides a unique competitive perspective. Every fortnight, its easy-to-read, well-indexed 36-40 page issue provides a wealth of comprehensive, highly detailed and well informed intelligence on:
Corporate News
The latest acquisition, merger, divestiture, restructuring and capital expenditure news.
Recent Agreements
Who's working with who, and on what? PCI will ensure you know about new deals, alliances and collaborations of all types.
Financial News
Up or down? Quarterly, half-yearly and annual financial results are regularly reported.
Product News
Monitor with ease the latest product filings, approvals and launches worldwide.
R&D News
A highly detailed round up of interesting primary research, drug development, clinical trials and patents.
A subscription to PCI will keep you informed and save you time and effort.
